Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
to study and predict. In this four-year SNF-funded project, you will develop data-driven, multiscale simulation methods that combine computer simulations, machine learning, and surrogate models to explore
-
First Stage Researcher (R1) Country Switzerland Application Deadline 23 Mar 2026 - 22:59 (UTC) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme
-
in X-ray imaging and microscopy techniques is a big plus. Experienced in project management and writing scientific publications. Fluent in English, German would be a plus, enjoying a multicultural
-
qualifications include: Hands-on experience with microbiological methods, material characterization, or polymer/ nanoparticle/ hydrogel synthesis. Strong analytical and problem-solving skills with high scientific
-
. Empa is a research institution of the ETH Domain. The Biointerfaces Laboratory is offering a Postdoc position focused on the development of in vitro simulation models for performance evaluation
-
-based materials and an application in agriculture, health and textiles, in order to identify application fields with high environmental sustainability potentials. This PhD position is part of the project
-
-vitro/ex-vivo performance testing Collaborate closely with polymer scientists, surgeons, microbiologists, and biomedical engineers Present your results in conferences and publish in peer-reviewed journals
-
mechanical experiments & hydrogen embrittlement: fracture toughness and fatigue crack growth experiments under high-pressure hydrogen environments, considering microstructure conditions of pipeline steels and
-
). Practical synthetic chemistry knowledge and polymer characterization is essential. Candidates with demonstrated research skills and high quality publications will be considered. Fluency in English is required
-
: Study activation under NIR light and assess catalytic and photothermal performance. Biomedical evaluation: Validate efficacy in vitro astrocytoma relapse models and ex vivo patient-derived tissue samples